Marshall University reports meningitis case in student
Officials with Marshall University announced Tuesday that a student has been diagnosed with bacterial meningitis. The student became ill over the weekend and has been hospitalized since Monday. Public domain image/Mikael More...
Novartis seeks FDA approval for meningitis B vaccine, Bexsero
Basel, June 17, 2014 – Novartis announced today the submission of a Biologic License Application (BLA) to the US Food and Drug Administration (FDA) for marketing approval for the use of Bexsero® (Multicomponent More...
Princeton researcher to conduct meningitis B vaccine study
Princeton University received attention back in March 2013 following eight cases of infection from serogroup B Neisseria meningitidis bacteria, and a total of nine cases associated with the university. To prevent More...
UC Santa Barbara will be offering the meningitis B vaccine, Bexsero, starting Feb. 24
In a follow-up to a story one month ago, The University of California, Santa Barbara (UCSB), who has experienced four cases of meningococcal meningitis group B during a three week time frame in Nov. 2013, will More...
Princeton vaccinates 4,361 with Bexsero with one clinic day left
Princeton University said Wednesday that more than 4,300 people received the first dose of the two-dose series of the meningococcal serogroup B vaccine after three days of clinic operations. Neisseria meningitidisImage/CDC As More...
Princeton announces dates for receiving meningitis B vaccine
The New Jersey university, which has experienced eight cases of serogroup B meningococcal disease since March, has announced the dates they will be administering the vaccine that helps protect against meningococcal More...
Bexsero, first Meningitis B vaccine, receives European Commission approval
Photo/CDC/ Debora Cartagena Switzerland-based pharmaceutical and health care company, Novartis announced this week that it’s Meningitis B vaccine, Bexsero, has received approval from the European Commission More...
